Serum Concentration of Adalimumab as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA)
Clinical trial NCT01382160 · COMPLETED
Trial details
- NCT number
- NCT01382160
- Sponsor
- University Hospital, Tours
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2013-07-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.